Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human,Mouse |
Host species | Goat |
Applications | ELISA,WB-Ce,IHC-P |
Brand: | Abnova |
Reference: | PAB6885 |
Product name: | CBX3 polyclonal antibody |
Product description: | Goat polyclonal antibody raised against synthetic peptide of CBX3. |
Gene id: | 11335 |
Gene name: | CBX3 |
Gene alias: | HECH|HP1-GAMMA|HP1Hs-gamma |
Gene description: | chromobox homolog 3 (HP1 gamma homolog, Drosophila) |
Immunogen: | A synthetic peptide corresponding to human CBX3. |
Immunogen sequence/protein sequence: | C-EAFLNSQKAGKEKD |
Protein accession: | NP_009207.2;NP_057671.2 |
Form: | Liquid |
Concentration: | 0.5 mg/mL |
Recommend dilutions: | ELISA (1:32000) Western blot (0.3-1.0 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-3 ug/mL) The optimal working dilution should be determined by the end user. |
Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Goat |
Antigen species / target species: | Human |
Specificity: | This antibody is not expected to cross-react with HP1-alpha and HP1-beta. NP_009207.2 and NP_057671.2 represent same protein. |
Reactivity: | Human,Mouse |
Application image: | ![]() |
Application image note: | CBX3 polyclonal antibody (Cat # PAB6885) (0.3 ug/mL) staining of A-431 lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
Applications: | ELISA,WB-Ce,IHC-P |
Shipping condition: | Dry Ice |
Publications: | Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin.Vakoc CR, Mandat SA, Olenchock BA, Blobel GA. Mol Cell. 2005 Aug 5;19(3):381-91. |